[ANZEN]Revisions of PRECAUTIONS: Inclisiran sodium,etc.posted
Safety Classified by Officially
(genetical recombination)
(genetical recombination)
[Tocilizumab biosimilar1]
(genetical recombination)
[Tocilizumab biosimilar2]
allylisopropylacetylurea/
anhydrous caffeine
anhydrous caffeine/
chlorpheniramine maleate
anhydrous caffeine/
promethazine methylenedisalicylate
dihydrocodeine phosphate/
dl-methylephedrine hydrochloride/
diphenhydramine salicylate/
acetaminophen/bromovalerylurea
tenofovir alafenamide fumarate
emtricitabine/
tenofovir alafenamide fumarate
rilpivirine hydrochloride
tenofovir alafenamide fumarate
tenofovir alafenamide fumarate
(Japanese strain)
(genetical recombination)
(Fiasp Injection 100U/mL)
(liposome formulations)
Amoxicillin Hydrate/Clarithromycin
Amoxicillin Hydrate/Metronidazole
(guidance-mandatory drugs)
(guidance-mandatory drugs)
(guidance-mandatorydrugs)
(oral dosage form)
(genetical recombination) and biosimilars
This is an extract. The publication continues at the source.
Source: Pharmaceuticals and Medical Devices Agency (Japan) website. Licence
Read the original at the source: https://www.pmda.go.jp/english/safety/info-services/drugs/revision-of-precautions/0014.html
Officially imported this from Pharmaceuticals and Medical Devices Agency (Japan)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
This publication has changed since it was first published
3 versions recorded. The original is kept in full — nothing is overwritten.
- v3 imported change on current
- v2 imported change on Titled: “[ANZEN]Revisions of PRECAUTIONS: Anamorelin hydrochloride,etc.posted”
- v1 as first published on Titled: “[ANZEN]Revisions of PRECAUTIONS: Cladribine posted”
Provenance
- Organization
- Pharmaceuticals and Medical Devices Agency (Japan) — imported from official source
- Official source
- https://www.pmda.go.jp/rss_008.xml RSS
- Imported
- October 03, 2026 20:39
- Versions
- 3 recorded
- Identity
-
https://www.pmda.go.jp/english/safety/info-services/drugs/revision-of-precautions/0014....